{
  "id": 5115822,
  "title": "UniQure, after setbacks, seeks FDA approval of Huntington’s gene therapy",
  "url": "https://urgent.news/2026/09/02/uniqure-after-setbacks-seeks-fda-approval-of-huntingtons-gene-therapy",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-02T15:22:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/uniqure-submit-fda-approval-huntingtons-gene-therapy/829400/"
  },
  "original_language": "en",
  "account": null,
  "summary": "The company is now hoping for an affirmative answer on its application after an unusually turbulent year dealing with U.S. regulators.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "STAT News",
        "title": "STAT+: Pharmalittle: We’re reading about a Huntington’s gene therapy, Novo’s challenges, and more",
        "url": "https://urgent.news/2026/09/02/stat-pharmalittle-were-reading-about-a-huntingtons-gene-therapy-novos",
        "published": "2026-09-02T13:26:55.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}